2021 Q1 Form 10-Q Financial Statement

#000157408521000056 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $83.85M $117.5M
YoY Change -28.65% -8.55%
Cost Of Revenue $28.50M $87.75M
YoY Change -67.52% 6.36%
Gross Profit $55.30M $29.77M
YoY Change 85.74% -35.29%
Gross Profit Margin 65.95% 25.33%
Selling, General & Admin $36.40M $55.30M
YoY Change -34.18% 3.17%
% of Gross Profit 65.82% 185.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $18.49M $18.55M
YoY Change -0.32% 10.35%
% of Gross Profit 33.44% 62.31%
Operating Expenses $59.50M $78.60M
YoY Change -24.3% 3.01%
Operating Profit -$3.707M -$3.227M
YoY Change 14.87% -122.92%
Interest Expense -$6.800M -$10.70M
YoY Change -36.45% -23.57%
% of Operating Profit
Other Income/Expense, Net $0.00 -$100.0K
YoY Change -100.0% 0.0%
Pretax Income -$10.89M -$14.02M
YoY Change -22.32% 3448.61%
Income Tax $145.0K $1.370M
% Of Pretax Income
Net Earnings -$8.708M -$12.93M
YoY Change -32.65% 1218.04%
Net Earnings / Revenue -10.39% -11.0%
Basic Earnings Per Share -$0.28 -$0.48
Diluted Earnings Per Share -$0.28 -$0.48
COMMON SHARES
Basic Shares Outstanding 39.61M shares 32.47M shares
Diluted Shares Outstanding 39.61M shares 32.47M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $85.70M $141.8M
YoY Change -39.56% 92.14%
Cash & Equivalents $85.68M $141.8M
Short-Term Investments
Other Short-Term Assets $6.800M $6.600M
YoY Change 3.03% -9.59%
Inventory $2.383M $2.718M
Prepaid Expenses
Receivables $17.60M $13.80M
Other Receivables $0.00 $0.00
Total Short-Term Assets $112.5M $164.9M
YoY Change -31.78% 54.4%
LONG-TERM ASSETS
Property, Plant & Equipment $1.407B $1.469B
YoY Change -4.27% 1.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.644M $1.900M
YoY Change -13.47% 1.5%
Other Assets $39.30M $45.40M
YoY Change -13.44% -47.39%
Total Long-Term Assets $1.568B $1.638B
YoY Change -4.24% -1.05%
TOTAL ASSETS
Total Short-Term Assets $112.5M $164.9M
Total Long-Term Assets $1.568B $1.638B
Total Assets $1.681B $1.803B
YoY Change -6.76% 2.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $74.10M $87.40M
YoY Change -15.22% 13.8%
Accrued Expenses $60.90M $61.10M
YoY Change -0.33% 0.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $141.4M $156.6M
YoY Change -9.71% 1.62%
LONG-TERM LIABILITIES
Long-Term Debt $1.119B $1.135B
YoY Change -1.38% 8.39%
Other Long-Term Liabilities $18.80M $17.90M
YoY Change 5.03% -32.45%
Total Long-Term Liabilities $1.138B $1.152B
YoY Change -1.28% 7.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $141.4M $156.6M
Total Long-Term Liabilities $1.138B $1.152B
Total Liabilities $1.279B $1.309B
YoY Change -2.29% 6.65%
SHAREHOLDERS EQUITY
Retained Earnings -$278.4M -$166.1M
YoY Change 67.63% 25.29%
Common Stock $434.0K $335.0K
YoY Change 29.55% 2.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $293.3M $358.6M
YoY Change
Total Liabilities & Shareholders Equity $1.681B $1.803B
YoY Change -6.76% 2.32%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$8.708M -$12.93M
YoY Change -32.65% 1218.04%
Depreciation, Depletion And Amortization $18.49M $18.55M
YoY Change -0.32% 10.35%
Cash From Operating Activities $11.97M -$865.0K
YoY Change -1483.47% 40.42%
INVESTING ACTIVITIES
Capital Expenditures -$4.690M -$7.510M
YoY Change -37.55% -94.95%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $200.0K $920.0K
YoY Change -78.26% -675.0%
Cash From Investing Activities -$4.492M -$6.587M
YoY Change -31.81% -95.58%
FINANCING ACTIVITIES
Cash Dividend Paid $2.555M $8.490M
YoY Change -69.91% 6.4%
Common Stock Issuance & Retirement, Net -$18.15M $28.00K
YoY Change -64932.14% -86.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $4.381M $64.28M
YoY Change -93.18% 25.71%
NET CHANGE
Cash From Operating Activities $11.97M -$865.0K
Cash From Investing Activities -$4.492M -$6.587M
Cash From Financing Activities $4.381M $64.28M
Net Change In Cash $11.86M $56.83M
YoY Change -79.14% -157.77%
FREE CASH FLOW
Cash From Operating Activities $11.97M -$865.0K
Capital Expenditures -$4.690M -$7.510M
Free Cash Flow $16.66M $6.645M
YoY Change 150.67% -95.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001574085
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-35972
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
BRAEMAR HOTELS & RESORTS INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2488594
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
14185 Dallas Parkway
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1200
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75254
CY2021Q1 dei City Area Code
CityAreaCode
972
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
490-9600
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47891046 shares
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1782753000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1784849000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
376243000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
360259000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1406510000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1424590000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85684000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78606000 USD
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
39322000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
34544000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
275000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
227000 USD
CY2021Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
17583000 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
13557000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
2383000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
2551000 USD
CY2021Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
6830000 USD
CY2020Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
4405000 USD
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
1644000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1708000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
80985000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
81260000 USD
CY2021Q1 us-gaap Other Assets
OtherAssets
15646000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
14898000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4546000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4640000 USD
CY2021Q1 us-gaap Due From Related Parties
DueFromRelatedParties
1052000 USD
CY2020Q4 us-gaap Due From Related Parties
DueFromRelatedParties
991000 USD
CY2021Q1 bhr Due From Third Party Hotel Managers
DueFromThirdPartyHotelManagers
18565000 USD
CY2020Q4 bhr Due From Third Party Hotel Managers
DueFromThirdPartyHotelManagers
12271000 USD
CY2021Q1 us-gaap Assets
Assets
1680750000 USD
CY2020Q4 us-gaap Assets
Assets
1674021000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
1118824000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
1130594000 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
74098000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
61758000 USD
CY2021Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2569000 USD
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2736000 USD
CY2021Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
2115000 USD
CY2020Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
2772000 USD
CY2021Q1 bhr Due To Third Party Hotel Managers
DueToThirdPartyHotelManagers
1725000 USD
CY2020Q4 bhr Due To Third Party Hotel Managers
DueToThirdPartyHotelManagers
1393000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
60857000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
60917000 USD
CY2021Q1 us-gaap Other Liabilities
OtherLiabilities
18833000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
18077000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
1279021000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1278247000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
96609000 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
106949000 USD
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
28162000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
27655000 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
80000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
80000000 shares
CY2021Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
16000 USD
CY2020Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
16000 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43465880 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43465880 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38274770 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38274770 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
434000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
382000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
571288000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
541870000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-278445000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-266010000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
293293000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
276258000 USD
CY2021Q1 us-gaap Minority Interest
MinorityInterest
-16335000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
-15088000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
276958000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
261170000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1680750000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1674021000 USD
CY2021Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
56042000 USD
CY2020Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
87748000 USD
CY2021Q1 bhr Property Taxes Insurance And Other
PropertyTaxesInsuranceAndOther
7264000 USD
CY2020Q1 bhr Property Taxes Insurance And Other
PropertyTaxesInsuranceAndOther
7660000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18353000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18338000 USD
CY2021Q1 bhr Advisory Services Fee
AdvisoryServicesFee
4795000 USD
CY2020Q1 bhr Advisory Services Fee
AdvisoryServicesFee
5069000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1600000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1932000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
88054000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
120747000 USD
CY2021Q1 bhr Gain Loss On Insurance Settlement And Disposition Of Assets
GainLossOnInsuranceSettlementAndDispositionOfAssets
499000 USD
CY2020Q1 bhr Gain Loss On Insurance Settlement And Disposition Of Assets
GainLossOnInsuranceSettlementAndDispositionOfAssets
0 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3707000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3227000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-64000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-40000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
9000 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
129000 USD
CY2021Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
0 USD
CY2020Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
138000 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
6756000 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
11897000 USD
CY2021Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
351000 USD
CY2020Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-20000 USD
CY2020Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1156000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10889000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14017000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
145000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1370000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-11034000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-15387000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-1247000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
-572000 USD
CY2021Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-1079000 USD
CY2020Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-1885000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8708000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-12930000 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2388000 USD
CY2020Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2555000 USD
CY2021Q1 bhr Gain Loss On Extinguishment Of Preferred Stock
GainLossOnExtinguishmentOfPreferredStock
-73000 USD
CY2020Q1 bhr Gain Loss On Extinguishment Of Preferred Stock
GainLossOnExtinguishmentOfPreferredStock
0 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11169000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15485000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39605000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32474000 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39605000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32474000 shares
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-11034000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-15387000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-11034000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-15387000 USD
CY2021Q1 bhr Comprehensive Income Loss Net Of Tax Portion Attributable To Nonredeemable Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxPortionAttributableToNonredeemableNoncontrollingInterest
-1247000 USD
CY2020Q1 bhr Comprehensive Income Loss Net Of Tax Portion Attributable To Nonredeemable Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxPortionAttributableToNonredeemableNoncontrollingInterest
-572000 USD
CY2021Q1 bhr Comprehensive Income Loss Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
-1079000 USD
CY2020Q1 bhr Comprehensive Income Loss Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
-1885000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8708000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12930000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
261170000 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
348000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1096000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18309000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0 USD
CY2021Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-9955000 USD
CY2021Q1 bhr Extinguishment Of Preferred Stock Value
ExtinguishmentOfPreferredStockValue
-10340000 USD
CY2021Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-1266000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
276958000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
363254000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
82000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1424000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2639000 USD
CY2020Q1 us-gaap Partners Capital Account Redemptions
PartnersCapitalAccountRedemptions
-3454000 USD
CY2020Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-13502000 USD
CY2020Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
6000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
349360000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-11034000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-15387000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18353000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18338000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1416000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1985000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
70000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
269000 USD
CY2021Q1 bhr Amortization Of Loan Costs And Capitalized Default Interest
AmortizationOfLoanCostsAndCapitalizedDefaultInterest
-583000 USD
CY2020Q1 bhr Amortization Of Loan Costs And Capitalized Default Interest
AmortizationOfLoanCostsAndCapitalizedDefaultInterest
1071000 USD
CY2021Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
351000 USD
CY2020Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 USD
CY2021Q1 bhr Depreciation And Amortization Excluding Intangible Assets
DepreciationAndAmortizationExcludingIntangibleAssets
138000 USD
CY2020Q1 bhr Depreciation And Amortization Excluding Intangible Assets
DepreciationAndAmortizationExcludingIntangibleAssets
207000 USD
CY2021Q1 bhr Amortization Of Non Refundable Membership Initiation Fees
AmortizationOfNonRefundableMembershipInitiationFees
194000 USD
CY2020Q1 bhr Amortization Of Non Refundable Membership Initiation Fees
AmortizationOfNonRefundableMembershipInitiationFees
82000 USD
CY2021Q1 bhr Interest Expense Accretion On Refundable Membership Club Deposits
InterestExpenseAccretionOnRefundableMembershipClubDeposits
202000 USD
CY2020Q1 bhr Interest Expense Accretion On Refundable Membership Club Deposits
InterestExpenseAccretionOnRefundableMembershipClubDeposits
213000 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
499000 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
CY2021Q1 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-20000 USD
CY2020Q1 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
1081000 USD
CY2021Q1 bhr Net Settlement Of Trading Derivatives
NetSettlementOfTradingDerivatives
0 USD
CY2020Q1 bhr Net Settlement Of Trading Derivatives
NetSettlementOfTradingDerivatives
-1330000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-64000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-40000 USD
CY2021Q1 bhr Deferred Tax Expense Benefit
DeferredTaxExpenseBenefit
-174000 USD
CY2020Q1 bhr Deferred Tax Expense Benefit
DeferredTaxExpenseBenefit
-5000 USD
CY2021Q1 bhr Increase Decrease In Accounts Receivable And Inventories
IncreaseDecreaseInAccountsReceivableAndInventories
3699000 USD
CY2020Q1 bhr Increase Decrease In Accounts Receivable And Inventories
IncreaseDecreaseInAccountsReceivableAndInventories
-4003000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3514000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2719000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16129000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8315000 USD
CY2021Q1 bhr Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
137000 USD
CY2020Q1 bhr Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
134000 USD
CY2021Q1 bhr Increase Decrease In Due To Related Parties Excluding Amounts Due To Affiliates
IncreaseDecreaseInDueToRelatedPartiesExcludingAmountsDueToAffiliates
-61000 USD
CY2020Q1 bhr Increase Decrease In Due To Related Parties Excluding Amounts Due To Affiliates
IncreaseDecreaseInDueToRelatedPartiesExcludingAmountsDueToAffiliates
-303000 USD
CY2021Q1 bhr Increase Decrease In Due To From Third Party Hotel Managers
IncreaseDecreaseInDueToFromThirdPartyHotelManagers
-5480000 USD
CY2020Q1 bhr Increase Decrease In Due To From Third Party Hotel Managers
IncreaseDecreaseInDueToFromThirdPartyHotelManagers
-337000 USD
CY2021Q1 bhr Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
60000 USD
CY2020Q1 bhr Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
54000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
748000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
267000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11967000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-865000 USD
CY2021Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
CY2020Q1 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
948000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
200000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2021Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
CY2020Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
26000 USD
CY2021Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
4692000 USD
CY2020Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
7509000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4492000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6587000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
75000000 USD
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
10832000 USD
CY2020Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
365000 USD
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2021Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
20000 USD
CY2020Q1 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
37000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
28000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
28000 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2555000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
8490000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
474000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18181000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2020Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
2639000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4381000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64280000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11856000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
56828000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113150000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130383000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125006000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187211000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
6892000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
10601000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-41000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
690000 USD
CY2021Q1 bhr Dividends And Distributions Declared But Not Paid
DividendsAndDistributionsDeclaredButNotPaid
2569000 USD
CY2020Q1 bhr Dividends And Distributions Declared But Not Paid
DividendsAndDistributionsDeclaredButNotPaid
3208000 USD
CY2021Q1 bhr Stock Repurchase Accrued But Not Paid
StockRepurchaseAccruedButNotPaid
348000 USD
CY2020Q1 bhr Stock Repurchase Accrued But Not Paid
StockRepurchaseAccruedButNotPaid
82000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4628000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17040000 USD
CY2021Q1 bhr Financing Costs Incurred But Not Yet Paid
FinancingCostsIncurredButNotYetPaid
0 USD
CY2020Q1 bhr Financing Costs Incurred But Not Yet Paid
FinancingCostsIncurredButNotYetPaid
1364000 USD
CY2021Q1 bhr Accrued Common Stock Offering Expense
AccruedCommonStockOfferingExpense
101000 USD
CY2020Q1 bhr Accrued Common Stock Offering Expense
AccruedCommonStockOfferingExpense
0 USD
CY2021Q1 bhr Unsettled Common Stock Offering Proceeds
UnsettledCommonStockOfferingProceeds
297000 USD
CY2020Q1 bhr Unsettled Common Stock Offering Proceeds
UnsettledCommonStockOfferingProceeds
0 USD
CY2021Q1 bhr Accrued Preferred Stock Offering Expense
AccruedPreferredStockOfferingExpense
0 USD
CY2020Q1 bhr Accrued Preferred Stock Offering Expense
AccruedPreferredStockOfferingExpense
25000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78606000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71995000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
34544000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
58388000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113150000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130383000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85684000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141793000 USD
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
39322000 USD
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
45418000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125006000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187211000 USD
CY2021Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
13 hotel
CY2021Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
13 hotel
CY2021Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
6 state
CY2021Q1 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
3722 room
CY2021Q1 bhr Number Of Units In Real Estate Property Net Partnership Interest
NumberOfUnitsInRealEstatePropertyNetPartnershipInterest
3487 room
CY2021Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
13 hotel
CY2021Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
13 hotel
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85700000 USD
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
39300000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12000000.0 USD
CY2021Q1 bhr Due From Third Party Hotel Managers
DueFromThirdPartyHotelManagers
18600000 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of these condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span>
CY2021Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
13 hotel
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83848000 USD
CY2020Q4 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
13 hotel
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117520000 USD
CY2021Q1 us-gaap Land
Land
455298000 USD
CY2020Q4 us-gaap Land
Land
455298000 USD
CY2021Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1190169000 USD
CY2020Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1190437000 USD
CY2021Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
127896000 USD
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
127692000 USD
CY2021Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
9390000 USD
CY2020Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
11422000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1782753000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1784849000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
376243000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
360259000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1406510000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1424590000 USD
CY2021Q1 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
481000 USD
CY2020Q1 bhr Proceeds From Insurance Settlement Operating And Investing Activities
ProceedsFromInsuranceSettlementOperatingAndInvestingActivities
2000000.0 USD
CY2021Q1 bhr Proceeds From Insurance Settlement Operating And Investing Activities
ProceedsFromInsuranceSettlementOperatingAndInvestingActivities
0 USD
CY2021Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2020Q3 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
10100000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-64000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-40000 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1117892000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1128724000 USD
CY2021Q1 bhr Debt Instrument Capitalized Default Interest And Late Fees
DebtInstrumentCapitalizedDefaultInterestAndLateFees
5994000 USD
CY2020Q4 bhr Debt Instrument Capitalized Default Interest And Late Fees
DebtInstrumentCapitalizedDefaultInterestAndLateFees
7304000 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5062000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5434000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
1118824000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
1130594000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-12930000 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2388000 USD
CY2021Q1 bhr Libor Interest Rate Forward Curve
LIBORInterestRateForwardCurve
0.00111
CY2020Q4 bhr Libor Interest Rate Forward Curve
LIBORInterestRateForwardCurve
0.00144
CY2021Q1 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
0 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1300000 USD
CY2021Q1 bhr Fair Value Consideration Threshold For Transfer In Out Of Level3
FairValueConsiderationThresholdForTransferInOutOfLevel3
0.10
CY2021Q1 bhr Libor Interest Rate Forward Curve
LIBORInterestRateForwardCurve
0.00111
CY2021Q1 bhr Maturity Period Of Cash And Cash Equivalents Maximum
MaturityPeriodOfCashAndCashEquivalentsMaximum
P90D
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1100000000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1100000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8708000 USD
CY2020Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2555000 USD
CY2021Q1 bhr Gain Loss On Extinguishment Of Preferred Stock
GainLossOnExtinguishmentOfPreferredStock
-73000 USD
CY2020Q1 bhr Gain Loss On Extinguishment Of Preferred Stock
GainLossOnExtinguishmentOfPreferredStock
0 USD
CY2021Q1 bhr Undistributed Net Income Loss Allocated To Common Stockholders
UndistributedNetIncomeLossAllocatedToCommonStockholders
-11169000 USD
CY2020Q1 bhr Undistributed Net Income Loss Allocated To Common Stockholders
UndistributedNetIncomeLossAllocatedToCommonStockholders
-15485000 USD
CY2021Q1 bhr Participating Securities Distributed And Undistributed Earnings Loss Basic And Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted
-11169000 USD
CY2020Q1 bhr Participating Securities Distributed And Undistributed Earnings Loss Basic And Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted
-15485000 USD
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39605000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39605000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32474000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32474000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2018Q3 bhr Advisory Agreement Interior Design Fees
AdvisoryAgreementInteriorDesignFees
0.06
CY2021Q1 bhr Net Income Loss Attributable To Antidilutive Securities
NetIncomeLossAttributableToAntidilutiveSecurities
557000 USD
CY2020Q1 bhr Net Income Loss Attributable To Antidilutive Securities
NetIncomeLossAttributableToAntidilutiveSecurities
-155000 USD
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10718000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11277000 shares
CY2021Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-1079000 USD
CY2020Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-1885000 USD
CY2020Q1 bhr Partners Capital Account Redemptions Historical Cost
PartnersCapitalAccountRedemptionsHistoricalCost
3500000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0 USD
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0 USD
CY2021Q1 bhr Related Party Transaction Base Fee112th Of Sum Of Market Capitalization And Net Asset Fee Adjustment
RelatedPartyTransactionBaseFee112thOfSumOfMarketCapitalizationAndNetAssetFeeAdjustment
0.0070
CY2021Q1 bhr Related Party Transaction Minimum Base Fee
RelatedPartyTransactionMinimumBaseFee
0.90
CY2021Q1 bhr Related Party Transaction Termof Advisory Agreement
RelatedPartyTransactionTermofAdvisoryAgreement
P3Y
CY2019Q3 bhr Contribution Agreement Preferred Equity Offering
ContributionAgreementPreferredEquityOffering
400000000 USD
CY2020 bhr Contribution Agreement Preferred Equity Offering
ContributionAgreementPreferredEquityOffering
400000000 USD
CY2020 bhr Contribution Agreement Capital Contributions
ContributionAgreementCapitalContributions
3750000 USD
CY2018Q3 bhr Advisory Agreement Architecture Fees
AdvisoryAgreementArchitectureFees
0.065
CY2018Q3 bhr Advisory Agreement Construction Management Fees
AdvisoryAgreementConstructionManagementFees
0.10
CY2018Q3 bhr Advisory Agreement Ffe Purchasing Fees
AdvisoryAgreementFFEPurchasingFees
0.08
CY2018Q3 bhr Advisory Agreement Ffe Purchasing Fees Freightand Tax Threshold
AdvisoryAgreementFFEPurchasingFeesFreightandTaxThreshold
2000000.0 USD
CY2018Q3 bhr Advisory Agreement Ffe Purchasing Feeswith Freightand Tax Threshold
AdvisoryAgreementFFEPurchasingFeeswithFreightandTaxThreshold
0.06
CY2018Q3 bhr Advisory Agreement Ffe Purchasing Fees Freightand Tax Threshold
AdvisoryAgreementFFEPurchasingFeesFreightandTaxThreshold
2000000.0 USD
CY2021Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
13 hotel
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment

Files In Submission

Name View Source Status
0001574085-21-000056-index-headers.html Edgar Link pending
0001574085-21-000056-index.html Edgar Link pending
0001574085-21-000056.txt Edgar Link pending
0001574085-21-000056-xbrl.zip Edgar Link pending
bhr-20210331.htm Edgar Link pending
bhr-20210331.xsd Edgar Link pending
bhr-20210331_cal.xml Edgar Link unprocessable
bhr-20210331_def.xml Edgar Link unprocessable
bhr-20210331_htm.xml Edgar Link completed
bhr-20210331_lab.xml Edgar Link unprocessable
bhr-20210331_pre.xml Edgar Link unprocessable
bhr2021q110-qxex106.htm Edgar Link pending
bhr2021q110-qxex107.htm Edgar Link pending
bhr2021q110-qxex311.htm Edgar Link pending
bhr2021q110-qxex312.htm Edgar Link pending
bhr2021q110-qxex321.htm Edgar Link pending
bhr2021q110-qxex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending